These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 29328410)
1. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis. Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410 [TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme. Zhang K; Li Q; Kang X; Wang Y; Wang S Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337 [TBL] [Abstract][Full Text] [Related]
3. Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis. Ma SC; Li Q; Peng JY; Zhouwen JL; Diao JF; Niu JX; Wang X; Guan XD; Jia W; Jiang WG CNS Neurosci Ther; 2017 Dec; 23(12):947-960. PubMed ID: 28961379 [TBL] [Abstract][Full Text] [Related]
4. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008 [TBL] [Abstract][Full Text] [Related]
6. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma. Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma. Luo Q; Cui M; Deng Q; Liu J Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192 [TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma. Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625 [TBL] [Abstract][Full Text] [Related]
9. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer. Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139 [TBL] [Abstract][Full Text] [Related]
10. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma. Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers. Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177 [TBL] [Abstract][Full Text] [Related]
12. Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma. Zhang Z; Wang S; Ji D; Qian W; Wang Q; Li J; Gu J; Peng W; Hu T; Ji B; Zhang Y; Wang S; Sun Y Oncol Rep; 2018 May; 39(5):2101-2113. PubMed ID: 29512732 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential prognostic long non‑coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma. Wang X; Ding Y; Da B; Fei Y; Feng G Oncol Rep; 2018 Dec; 40(6):3199-3212. PubMed ID: 30272355 [TBL] [Abstract][Full Text] [Related]
14. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer. Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer. Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479 [TBL] [Abstract][Full Text] [Related]
16. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes. Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017 [TBL] [Abstract][Full Text] [Related]
17. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour. Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887 [TBL] [Abstract][Full Text] [Related]
18. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer. Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158 [TBL] [Abstract][Full Text] [Related]
19. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059 [TBL] [Abstract][Full Text] [Related]
20. Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma. Yuan Y; Jiaoming L; Xiang W; Yanhui L; Shu J; Maling G; Qing M J Neurooncol; 2018 May; 137(3):493-502. PubMed ID: 29335913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]